Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint

Annals of the Rheumatic Diseases

Volumn 69, Issue 6, 2010, Pages 1172-1178

  Biniecka, Monika ^a   Kennedy, Aisling ^a   Fearon, Ursula ^a   Ng, Chin Teck ^a   Veale, Douglas J ^a   O'Sullivan, Jacintha N ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOPURINE; 4 HYDROXYNONENAL; ANGIOPOIETIN 2; BIOLOGICAL MARKER; C REACTIVE PROTEIN; LYSINE DERIVATIVE; OXYGEN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTHRITIS; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATORY ARTHRITIS; LIPID PEROXIDATION; MALE; MECHANICAL PROBE; OXIDATION; OXYGEN TENSION; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INDUCING AGENTS; ARTHRITIS; ARTHROSCOPY; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; CELL HYPOXIA; DNA DAMAGE; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXYGEN; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 77952963790     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.111211     Document Type: Article

References (73)

1. Sweeney SE, Firestein GS. Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol 2004;36:372-8.
2. Tak PP, Zvaifler NJ, Green DR, et al. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 2000;21:78-82.
3. Karouzakis E, Neidhart M, Gay RE, et al. Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett 2006;106:8-13.
4. Etherington PJ, Winlove P, Taylor P, et al. VEGF release is associated with reduced oxygen tensions in experimental inflammatory arthritis. Clin Exp Rheumatol 2002;20:799-805. (Pubitemid 35446970)
5. Koch AE. Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2003;62(Suppl 2):ii60-7.
6. Taylor PC, Sivakumar B. Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol 2005;17:293-8.
7. Distler JH, Wenger RH, Gassmann M, et al. Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2004;50:10-23.
8. Filippin LI, Vercelino R, Marroni NP, et al. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 2008;152:415-22.
9. Mirshafiey A, Mohsenzadegan M. The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. Iran J Allergy Asthma Immunol 2008;7:195-202.
10. Taylor CT. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J 2008;409:19-26.
11. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex. III: The paradox of increased reactive oxygen species during hypoxia. Exp Physiol 2006;91:807-19.
12. Seven A, Güzel S, Aslan M, et al. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin Biochem 2008;41:538-43.
13. Pacifici RE, Davies KJ. Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology 1991;37:166-80.
14. Valko M, Izakovic M, Mazur M, et al. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004;266:37-56.
15. Minuz P, Fava C, Cominacini L. Oxidative stress, antioxidants, and vascular damage. Br J Clin Pharmacol 2006;61:774-7.
16. Sheridan J, Wang LM, Tosetto M, et al. Nuclear oxidative damage correlates with poor survival in colorectal cancer. Br J Cancer 2009;100:381-8.
17. Maurice MM, Nakamura H, van der Voort EA, et al. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol 1997;158:1458-65.
18. Maurice MM, Nakamura H, Gringhuis S, et al. Expression of the thioredoxinthioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 1999;42:2430-9.
19. Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004;6:265-78.
20. Remans PH, van Oosterhout M, Smeets TJ, et al. Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 2005;52:2003-9.
21. Cooke MS, Olinski R, Evans MD. Does measurement of oxidative damage to DNA have clinical significance? Clin Chim Acta 2006;365:30-49.
22. Catalá A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids 2009;157:1-11.
23. Yang Y, Sharma R, Sharma A, et al. Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim Pol 2003;50:319-36. (Pubitemid 37034689)
24. Lelkes PI, Hahn KL, Sukovich DA, et al. On the possible role of reactive oxygen species in angiogenesis. Adv Exp Med Biol 1998;454:295-310. (Pubitemid 29005542)
25. Giatromanolaki A, Sivridis E, Maltezos E, et al. Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2003;5:R193-201.
26. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
27. Veale D, Rogers S, Fitzgerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994;33:133-8. (Pubitemid 24051604)
28. Veale DJ. The role of arthroscopy in early arthritis. Clin Exp Rheumatol 1999;17:37-8.
29. Youssef PP, Kraan M, Breedveld F, et al. Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy. Arthritis Rheum 1998;41:663-9.
30. Tak PP, van der Lubbe PA, Cauli A, et al. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 1995;38:1457-65.
31. Bashir S, Harris G, Denman MA, et al. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 1993;52:659-66.
32. Lunec J, Herbert K, Blount S, et al. 8-Hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett 1994;348:131-8. (Pubitemid 124012896)
33. Hajizadeh S, DeGroot J, TeKoppele JM, et al. Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther 2003;5:R234-40.
34. Toyokuni S, Tanaka T, Hattori Y, et al. Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45. 1: Its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997;76:365-74.
35. Leitinger N. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans. Subcell Biochem 2008;49:325-50.
36. Henrotin YE, Bruckner P, Pujol JP. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr Cartil 2003;11:747-55.
37. Ramos VA, Ramos PA, Dominguez MC. [Role of oxidative stress in the maintenance of inflamation in patients with juvenile rheumatoid arthritis]. J Pediatr (Rio J) 2000;76:125-32.
38. Jaswal S, Mehta HC, Sood AK, et al. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 2003;338:123-9.
39. Kamanli A, Naziroglu M, Aydilek N, et al. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct 2004;22:53-7.
40. Selley ML, Bourne DJ, Bartlett MR, et al. Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1992;51:481-4.
41. Poli G, Schaur RJ, Siems WG, et al. 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev 2008;28:569-631.
42. Barrera G, Pizzimenti S, Muraca R, et al. Effect of 4-hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells. Free Radic Biol Med 1996;20:455-62.
43. Awasthi YC, Sharma R, Cheng JZ, et al. Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol Aspects Med 2003;24:219-30.
44. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003;42:318-43.
45. Shi Q, Vaillancourt F, Côté V, et al. Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal. Arthritis Res Ther 2006;8:R159.
46. Vaillancourt F, Fahmi H, Shi Q, et al. 4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: the protective role of glutathione-S-transferase. Arthritis Res Ther 2008;10:R107.
47. Jeon CH, Ahn JK, Chai JY, et al. Hypoxia appears at pre-arthritic stage and shows co-localization with early synovial inflammation in collagen induced arthritis. Clin Exp Rheumatol 2008;26:646-8.
48. Humphries KM, Yoo Y, Szweda LI. Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. Biochemistry 1998;37:552-7.
49. Pecqueur C, Alves-Guerra MC, Gelly C, et al. Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem 2001;276:8705-12.
50. Brand MD, Pamplona R, Portero-Otín M, et al. Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3. Biochem J 2002; 368(Pt 2):597-603.
51. Chen JJ, Yu BP. Alterations in mitochondrial membrane fluidity by lipid peroxidation products. Free Radic Biol Med 1994;17:411-8.
52. Kumagai T, Kawamoto Y, Nakamura Y, et al. 4-Hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochem Biophys Res Commun 2000;273:437-41.
53. Amin AR, Attur M, Patel RN, et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 1997;99:1231-7.
54. Martel-Pelletier J, Pelletier JP, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 2003;33:155-67.
55. Cillero-Pastor B, Caramés B, Lires-Deán M, et al. Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheum 2008;58:2409-19.
56. Kumagai T, Matsukawa N, Kaneko Y, et al. A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J Biol Chem 2004;279:48389-96.
57. Vaillancourt F, Morquette B, Shi Q, et al. Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade. J Cell Biochem 2007;100:1217-31.
58. Page S, Fischer C, Baumgartner B, et al. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J Biol Chem 1999;274:11611-18.
59. Minekura H, Kumagai T, Kawamoto Y, et al. 4-Hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response. Biochem Biophys Res Commun 2001;282:557-61.
60. Ruef J, Moser M, Bode C, et al. 4-Hydroxynonenal induces apoptosis, NF-kappaBactivation and formation of 8-isoprostane in vascular smooth muscle cells. Basic Res Cardiol 2001;96:143-50.
61. Luczak K, Balcerczyk A, Soszynski M, et al. Low concentration of oxidant and nitric oxide donors stimulate proliferation of human endothelial cells in vitro. Cell Biol Int 2004;28:483-6.
62. Shono T, Ono M, Izumi H, et al. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 1996;16:4231-9.
63. Vepa S, Scribner WM, Parinandi NL, et al. Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. Am J Physiol 1999;277(1 Pt 1):L150-8.
64. Ushio-Fukai M, Tang Y, Fukai T, et al. Novel role of gp91(phox)- containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2002;91:1160-7.
65. Harfouche R, Malak NA, Brandes RP, et al. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB J 2005;19:1728-30.
66. Shimizu S, Yasuda M, Ishii M, et al. Stimulation of in vitro angiogenesis by tetrahydrobiopterin in bovine aortic endothelial cells. Jpn J Pharmacol 1999;80:177-80.
67. Yasuda M, Shimizu S, Tokuyama S, et al. A novel effect of polymorphonuclear leukocytes in the facilitation of angiogenesis. Life Sci 2000;66:2113-21.
68. Oh H, Takagi H, Suzuma K, et al. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999;274:15732-9. (Pubitemid 129518932)
69. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 2002;99:11205-10.
70. Sarban S, Kocyigit A, Yazar M, et al. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 2005;38:981-6.
71. Chaturvedi V, Handa R, Rao DN, et al. Estimation and significance of serum and synovial fluid malondialdehyde levels in rheumatoid arthritis. Indian J Med Res 1999;109:170-4.
72. Scofield RH, Kurien BT, Ganick S, et al. Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic Biol Med 2005;38:719-28.
73. Kurien BT, Scofield RH. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008;7:567-73.